Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market TodayZacks Investment Research • 07/22/24
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall StreetThe Motley Fool • 07/21/24
The Zacks Analyst Blog ASML, SAP, Nvidia, Vertex and EssilorLuxxotticaZacks Investment Research • 07/16/24
Orum Therapeutics Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of Orum's TPD²® Technology to Develop Novel Degrader-Antibody ConjugatesBusiness Wire • 07/16/24
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).The Motley Fool • 07/06/24
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic FibrosisBusiness Wire • 07/02/24